What is Leash Bio?
Leash Bio is revolutionizing the drug discovery process through the application of machine learning. The company focuses on generating a vast and proprietary dataset by screening millions of compounds against thousands of proteins. This approach produces billions of data points, which are used to train advanced machine learning models.
Leash Bio operates on a dynamic, cyclical engine that continuously integrates data, iterates machine learning processes, and refines its methodologies. This efficient process allows for rapid advancements in drug design, with each cycle taking only a few months.
Features
- Rich Dataset: Screening millions of compounds against thousands of proteins to generate billions of data points.
- Machine Learning Models: Training advanced machine learning models with the proprietary dataset.
- Cyclical Engine: Continuously harnessing data, iterating machine learning, and refining the approach in cycles of a few months.
- Scalable Software: Rapidly designing new molecules with a higher likelihood of desired activities.
- Internal Programs: Developing new medicines, initially focusing on two oncology targets.
Use Cases
- Accelerating drug discovery for various diseases.
- Developing new medicines in oncology.
- Collaborating with biopharma partners to explore new molecule opportunities.
Helpful for people in the following professions
Leash Bio Uptime Monitor
Average Uptime
100%
Average Response Time
260.7 ms
Featured Tools
Angel.ai
Chat with your favourite AI Girlfriend
CapMonster Cloud
Highly efficient service for solving captchas using AI
GoStudio
Professional Headshots Using Your Selfies
Adola
AI-powered voice assistants for seamless business communication
Send AI
Secure Document Processing with AI
Producti AI
Unleash the Power of AI
Boosted.ai
Artificial intelligence software that helps investment managers save time, improve portfolio metrics, and make better, data-driven decisionsJoin Our Newsletter
Stay updated with the latest AI tools, news, and offers by subscribing to our weekly newsletter.
